OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cyclin-dependent kinase 4/6 inhibitors for cancer therapy: a patent review (2015 – 2019)
Pengfei Wang, Han‐Yue Qiu, Yun He, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 10, pp. 795-805
Closed Access | Times Cited: 8

Showing 8 citing articles:

An update of new small-molecule anticancer drugs approved from 2015 to 2020
Xiaoxia Liang, Pan Wu, Qian Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113473-113473
Closed Access | Times Cited: 39

A patent review of anticancer CDK2 inhibitors (2017–present)
Mohamed A. Said, Mohamed A. Abdelrahman, Mohammed A. S. Abourehab, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 8, pp. 885-898
Closed Access | Times Cited: 15

The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives
Nicole Brighi, Vincenza Conteduca, Cristian Lolli, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 157, pp. 103199-103199
Closed Access | Times Cited: 21

Iron oxide nanoparticles for biomedical applications: an updated patent review (2015–2021)
Zeyuan Mao, Xin Li, Pengfei Wang, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 9, pp. 939-952
Closed Access | Times Cited: 10

Development of New Meridianin/Leucettine-Derived Hybrid Small Molecules as Nanomolar Multi-Kinase Inhibitors with Antitumor Activity
Mohamed H. Elsherbeny, Ahmed Elkamhawy, Hossam Nada, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1131-1131
Open Access | Times Cited: 10

Design, synthesis and biological assessment of novel CDK4 inhibitor with potent anticancer activity
Yongtao Li, Renle Du, Yongwei Nie, et al.
Bioorganic Chemistry (2021) Vol. 109, pp. 104717-104717
Closed Access | Times Cited: 8

THE MOLECULAR APPROACH OF NATURAL PRODUCTS AS PANCREATIC CANCER TREATMENT: A REVIEW
Muhammad Fauzan Lubis, Poppy Anjelisa Zaitun Hasibuan, Urip Harahap, et al.
RASAYAN Journal of Chemistry (2022) Vol. 15, Iss. 02, pp. 1362-1377
Open Access | Times Cited: 4

Long noncoding RNA SNHG6 promotes papillary thyroid cancer cells proliferation via regulating miR-186/CDK6 axis
Jian Xu, Miaomiao Liao
Gland Surgery (2021) Vol. 10, Iss. 10, pp. 2935-2944
Open Access | Times Cited: 3

Page 1

Scroll to top